Abstract: The present invention includes compounds, pharmaceuticals and cosmetics having at least one (substituted phenyl)-propenal moiety. The compounds and compositions of the present invention are useful in the treatment or prevention of medical conditions including androgen associated conditions, androgen associated inflammation, a wound (the compounds assist with wound healing), acne, rheumatoid arthritis, psoriasis, rosacea, and alopecia; Kennedy's disease (spinal and bulbar muscular atrophy, or SBMA), polyglutamine-mediated motor neuron degeneration; cancers such as prostate cancer, bladder cancer, breast cancer, ovarian cancer, hepatocellular (liver) cancer, and pancreatic cancer; and other medical conditions described herein. Treatment of such medical conditions includes administering to an individual suffering from a medical condition describe herein, a therapeutically effective amount of any of the disclosed compounds, their derivatives, or pharmaceutical compositions thereof.

Abstract: A method and system for remote control and remote-controlled user interface. A remote control method of target terminal by a mobile communication terminal comprises: displaying a plurality of control methods for remote control of the target terminal; when one of the plurality of control methods is selected, displaying a control screen corresponding to the selected control method; and when a control attribute value displayed in the control screen is set, transmitting a control message comprising the set control attribute value to the target terminal, wherein the control methods include at least one of a directional touch, a tilt and a pattern input by continuous touch.

Abstract: A method of treating cancer, inflammatory disease, and autoimmune disease by administering to a subject in need thereof an effective amount of one or more 1,5-dipenylpenta-1,4-dien-3-one compounds. The compounds feature either or both of the phenyl rings being substituted with hydroxyl, diethyl(2-alkoxyethyl)amine, 1-(2-alkoxyethyl)piperidine, sulfonate, phosphinate, or phosphate.

Abstract: An apparatus and a method for sensory-type learning are disclosed. An apparatus for sensory-type learning comprises: a video divider configured to divide a video of a recorded learner into a plurality of blocks, and divide the video which has been divided into a plurality of blocks into previously set time intervals; a differential video extractor configured to extract a differential video; an object domain generator configured to generate a first object domain, which is a single object domain; a contact determiner configured to determine whether the first object domain came into contact with a second object domain pertaining to a background object appearing on a screen; and a movement controller configured to apply the change in animation to the background object and control the apparatus for sensory-type learning to execute a previously set movement.

Abstract: The present invention relates to a method for integrating information on external application with information on internal application. The method includes steps of: (a) classifying information inputted from internal application and external application into either common information or specialized information; (b) deciding whether common information of the external application should be matched with that of the internal application by referring to a matching algorithm and then matching the common information of the external application with that of the internal application, if necessary, and matching the specialized information of the external application with that of the internal application; and (c) providing common information at states of being matched or unmatched according to the matching algorithm through the template and the matched specialized information through the template.

Abstract: A mobile device such as a tablet computer accesses a server to search a product catalog. The catalog is displayed as a broad classifications of products, which when selected result in the display of sub-classifications within the classification. Levels of searching are provided to the product level, and movement within each level is possible.

Abstract: Rapid lateral flow immunoassays have an extensive history of use in both the clinical and home settings. These devices are used to test for a variety of analytes, such as drugs of abuse, hormones, proteins, urine or plasma components and the like. The present invention provides an improved procedural control that indicates to the test user that at least a portion of the applied sample has passed through the test result zone of the test strip, and optionally that the test is complete and the test results may be read.

Abstract: This invention relates to compounds of Formula (I), (II), or (III) as shown in the specification, which contain a 1,5-diphenylpenta-1,4-dien-3-one backbone. These compounds can be used to treat cancer, inflammatory disease, or autoimmune disease.

Abstract: A method and system for predicting performance of an application on a machine of a predetermined hardware configuration simulates the performance of the application under a plurality of different simulated hardware configurations; builds a predictive model of the performance of the application based on the results of the simulations; obtains the performance of the application on a plurality of actual machines, each of the machines having a different hardware configuration; and Bayesian reinterprets the predictive model built from the results of the simulations using the performance of the application on the plurality of actual machines, to obtain a final predictive model of the performance of the application having an accuracy greater than the predictive model built from the results of the simulations.

Abstract: Disclosed is a depolymerized glycosaminoglycan from Thelenota ananas (dTHG), weight average molecular weight of which is about 8000˜20000 Da, and monosaccharide components of which are acetylgalactosamine (GalNAc), glucuronic acid (GlcUA), fucose (Fuc) or their sulfates (expressed as —OSO3?), in which molar ratio of GalNAc:GlcUA:Fuc:—OSO3? is about 1:(1±0.3):(1±0.3):(3.5±0.5). Said dTHG is a potent endogenous inhibitor of factor X, which has good anticoagulant and antithrombotic activity, and can be used for the prevention and/or treatment of thrombotic diseases. Also provided is a method for preparing said dTHG, which comprises steps of 1) extracting and obtaining fucosylated glycosaminoglycan (THG) from the body wall of Thelenota ananas; 2) depolymerizing THG to obtain dTHG by method of peroxide depolymerization or method of peroxide depolymerization catalyzed by catalyst of the fourth period transition metal ions; 3) removing impurities with lower and/or higher molecular weight in dTHG.

Abstract: In at least one example embodiment, a method may include generating, regarding a rendered HTML page, an output image having a plurality of macroblocks; classifying each of the plurality of macroblocks into one of a variable macroblock and an invariable macroblock; generating an encoding map regarding the output image based at least in part on the result of the classifying; and encoding the output image based at least in part on the encoding map.

Abstract: The present invention includes compounds, pharmaceuticals and cosmetics having at least one (substituted phenyl)-propenal moiety. The compounds and compositions of the present invention are useful in the treatment or prevention of medical conditions including androgen associated conditions, androgen associated inflammation, a wound (the compounds assist with wound healing), acne, rheumatoid arthritis, psoriasis, rosacea, and alopecia; Kennedy's disease (spinal and bulbar muscular atrophy, or SBMA), polyglutamine-mediated motor neuron degeneration; cancers such as prostate cancer, bladder cancer, breast cancer, ovarian cancer, hepatocellular (liver) cancer, and pancreatic cancer; and other medical conditions described herein. Treatment of such medical conditions includes administering to an individual suffering from a medical condition describe herein, a therapeutically effective amount of any of the disclosed compounds, their derivatives, or pharmaceutical compositions thereof.

Abstract: The present invention relates to norbornene-ester-based derivatives, to a method for preparing same, and to the uses thereof. This compound may be used as a plasticizer which can replace a phthalate-based plasticizer.

Abstract: The present invention includes compounds, pharmaceuticals and cosmetics having at least one (substituted phenyl)-propenal moiety. The compounds and compositions of the present invention are useful in the treatment or prevention of medical conditions including androgen associated conditions, androgen associated inflammation, a wound (the compounds assist with wound healing), acne, rheumatoid arthritis, psoriasis, rosacea, and alopecia; Kennedy's disease (spinal and bulbar muscular atrophy, or SBMA), polyglutamine-mediated motor neuron degeneration; cancers such as prostate cancer, bladder cancer, breast cancer, ovarian cancer, hepatocellular (liver) cancer, and pancreatic cancer; and other medical conditions described herein. Treatment of such medical conditions includes administering to an individual suffering from a medical condition describe herein, a therapeutically effective amount of any of the disclosed compounds, their derivatives, or pharmaceutical compositions thereof.

Abstract: The present invention relates to a novel crystalline form of a Compound 3,4?,5-trihydroxy-stilbene-3-?-D-glucoside (polydatin) and a method of preparation and use thereof, and to a pharmaceutical composition containing crystalline form I of 3,4?,5-trihydroxy-stilbene-3-?-D-glucoside. Crystalline form I of 3,4?,5-trihydroxy-stilbene-3-?-D-glucoside of the present invention has a stable crystalline morphology, a definite melting point and a good chemical stability. Such a novel form of 3,4?,5-trihydroxy-stilbene-3-?-D-glucoside possesses the properties required for the preparation of solid formulations and is easily tabletable and readily formable when formulated, which allows for substantial decrease in raw materials costs, more facile operations in production and easier control over quality in industrial drug production, and moreover, better convenience in storage.

Abstract: The present invention includes compounds, pharmaceuticals and cosmetics having at least one (substituted phenyl)-propenal moiety. The compounds and compositions of the present invention are useful in the treatment or prevention of medical conditions including androgen associated conditions, androgen associated inflammation, a wound (the compounds assist with wound healing), acne, rheumatoid arthritis, psoriasis, rosacea, and alopecia; Kennedy's disease (spinal and bulbar muscular atrophy, or SBMA), polyglutamine-mediated motor neuron degeneration; cancers such as prostate cancer, bladder cancer, breast cancer, ovarian cancer, hepatocellular (liver) cancer, and pancreatic cancer; and other medical conditions described herein. Treatment of such medical conditions includes administering to an individual suffering from a medical condition describe herein, a therapeutically effective amount of any of the disclosed compounds, their derivatives, or pharmaceutical compositions thereof.

Abstract: An apparatus for managing a plurality of services is disclosed. The apparatus includes a communication unit configured to receive a message that requests initiation of at least one of the plurality of services from at least one of a plurality of user devices through a network, a plurality of service providing platforms configured to provide the plurality of services to the plurality of user devices, and a service management unit configured to, when a message that requests initiation of a first service of the plurality of services is received from a first user device by the communication unit, send a control command for initiating a connection of a first service providing platform, which provides the first service among the plurality of service providing platforms, with the first user device.

Abstract: A device for using display history information is provided. The device includes an image information generation unit configured to generate image information of contents reproduced in a different device, an image information transmission unit configured to transmit the generated image information to a seamless service providing server and a display history information management unit configured to control the apparatus based on the received display history information which is received from the seamless service providing server. Here, the display history information corresponds to the transmitted image information.

Abstract: Disclosed is a depolymerized glycosaminoglycan from Thelenota ananas (dTHG), weight average molecular weight of which is about 8000˜20000 Da, and monosaccharide components of which are acetylgalactosamine (GalNAc), glucuronic acid (GlcUA), fucose (Fuc) or their sulfates (expressed as —OSO3?), in which molar ratio of GalNAc:GlcUA:Fuc:—OSO3? is about 1:(1±0.3):(1±0.3):(3.5±0.5). Said dTHG is a potent endogenous inhibitor of factor X, which has good anticoagulant and antithrombotic activity, and can be used for the prevention and/or treatment of thrombotic diseases. Also provided is a method for preparing said dTHG, which comprises steps of 1) extracting and obtaining fucosylated glycosaminoglycan (THG) from the body wall of Thelenota ananas; 2) depolymerizing THG to obtain dTHG by method of peroxide depolymerization or method of peroxide depolymerization catalyzed by catalyst of the fourth period transition metal ions; 3) removing impurities with lower and/or higher molecular weight in dTHG.